Statins are prone to diabetes and skin infections

Statins are prone to diabetes and skin infections

We are searching data for your request:

Forums and discussions:
Manuals and reference books:
Data from registers:
Wait the end of the search in all databases.
Upon completion, a link will appear to access the found materials.

Controversy over statins continues

A recent study shows that taking statins for three months is associated with an increased risk of diabetes and skin and soft tissue infections. The study team emphasized that doctors and those affected should know the connection and, if necessary, monitor the blood sugar level while taking it.

"We believe the results will increase the need for physicians to be aware that statin use is linked to diabetes and skin infections," said lead author Humphrey Ko of Curtin University, Australia. The study was recently published in the British Journal of Clinical Pharmacology.

Statins as a risk factor for diabetes?

In a recent study, the Australian research team analyzed data from 2001 to 2011 that resulted from prescription claims. The study concluded that statins are associated with a significant risk of diabetes. In addition, people with diabetes who took statins had a significantly higher risk of skin and soft tissue infections. But the risk of skin infections also seems to be increased in non-diabetics.

Read on:
- High cholesterol: two injections per year instead of statins
- Statins effective and alleged side effects completely exaggerated?

Use of statin is considered controversial

Statins are often used in people with high cholesterol and are intended to protect against hardening of the arteries (atherosclerosis) and its consequences such as heart disease and heart attack. The studies on the subject have been controversial for years. Some studies have come to the conclusion that statins can cause liver damage and osteoporosis, while other studies claim that the use of cholesterol-lowering drugs would also make sense in people without high cholesterol levels.

Are statin intakes superfluous for every second person?

An analysis by the University of Zurich also concluded that every second patient takes statins for free. In particular, the benefits for senior citizens are greatly overestimated. The current study by Curtin University underlines the position that the target group benefiting from statins must be determined more precisely and for whom the disadvantages outweigh. (vb)

Author and source information

This text corresponds to the specifications of the medical literature, medical guidelines and current studies and has been checked by medical doctors.

Graduate editor (FH) Volker Blasek


  • Humphrey H.T. Ko, Ricky R. Lareu, Brett R. Dix, et al .: A sequence symmetry analysis of the interrelationships between statins, diabetes, and skin infections, British Journal of Clinical Pharmacology, 2019,
  • Henock G. Yebyo, Hélène E. Aschmann, Milo A. Puhan: Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study, Annals of Internal Medicine, 2019,
  • Michael Leutner, Caspar Matzhold, Luise Bellach, u.a .: Diagnosis of osteoporosis in statin-treated patients is dose-dependent, Annals of the Rheumatic Diseases, 2019,
  • Rüdiger Meyer: Cholesterol-lowering: Statins in constant discourse, Dtsch Arzteblatt, 2019,

Video: Diabetics are prone to skin conditions (August 2022).